Blb&B Advisors, LLC Amgen Inc Transaction History

Blb&B Advisors, LLC

$1.82 Billion
Q2 2024

A detailed history of Blb&B Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Blb&B Advisors, LLC holds 4,221 shares of AMGN stock, worth $1.36 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,221

Previous 3,904 8.12%

Holding current value

$1.36 Million

Previous $1.11 Million 18.85%

% of portfolio

0.07%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $83,291 - $101,221	317 Added 8.12%	4,221 $1.32 Million
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $4,033 - $4,868	15 Added 0.39%	3,904 $1.11 Million
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $28,382 - $32,019	111 Added 2.94%	3,889 $1.12 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $30,611 - $38,004	140 Added 3.85%	3,778 $1.02 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $7,285 - $8,614	-34 Reduced 0.93%	3,638 $807,000
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $4,064 - $4,953	18 Added 0.49%	3,672 $887,000
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $11,451 - $14,550	-50 Reduced 1.35%	3,654 $0
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $7,407 - $8,353	33 Added 0.9%	3,704 $835,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.27%	3,671 $893,000
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $3,727 - $4,123	-17 Reduced 0.46%	3,681 $890,000
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $71,596 - $81,936	-360 Reduced 8.87%	3,698 $832,000
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $147,527 - $172,846	695 Added 20.67%	4,058 $863,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $22,657 - $25,136	-97 Reduced 2.8%	3,363 $820,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $143,131 - $166,797	-645 Reduced 15.71%	3,460 $861,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $60,153 - $71,632	278 Added 7.26%	4,105 $944,000
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $2,815 - $3,131	12 Added 0.31%	3,827 $973,000
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $10,483 - $12,865	-53 Reduced 1.37%	3,815 $900,000
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $41,915 - $55,591	230 Added 6.32%	3,868 $784,000
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $3,784 - $4,864	20 Added 0.55%	3,638 $877,000
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $116,131 - $139,149	-667 Reduced 15.57%	3,618 $700,000
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $21,504 - $25,207	129 Added 3.1%	4,285 $790,000
Q1 2019 Apr 19, 2019	SELL	$180.87 - $203.88 $180,870 - $203,880	-1,000 Reduced 19.39%	4,156 $790,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $9,633 - $11,245	-54 Reduced 1.04%	5,156 $1 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $175,284 - $197,609	-946 Reduced 15.37%	5,210 $1.08 Million
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $7,804 - $8,765	-47 Reduced 0.76%	6,156 $1.14 Million
Q1 2018 Apr 09, 2018	SELL	$169.43 - $198.0 $25,414 - $29,700	-150 Reduced 2.36%	6,203 $1.06 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $155,286 - $173,502	920 Added 16.93%	6,353 $1.11 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $908,886 - $1.04 Million	5,433	5,433 $1.01 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Amgen Inc Transaction History